Trial Information
LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma
Inclusion Criteria:
- Non-Hodgkin's Lymphoma stages III, IV, IVA with
1. T cell lymphomas, any primary site irrespective of LDH level
2. large cell lymphomas, any primary site irrespective of LDH level
3. B cell lymphomas, any primary site with initial LDH of less than 500
Exclusion Criteria:
- B cell lymphomas, any primary site with initial LDH of less than 500 and initial CNS
or bone involvement
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Non-Hodgkin Cancer does not return 3 years after completing treatment
Outcome Time Frame:
330 Days
Safety Issue:
Yes
Principal Investigator
Tanya Trippett, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Memorial Sloan-Kettering Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
90-042
NCT ID:
NCT00610883
Start Date:
May 1990
Completion Date:
December 2008
Related Keywords:
- Non-Hodgkin's Lymphoma
- Lymphoma
- Lymphoma, Non-Hodgkin
Name | Location |
Memorial Sloan-Kettering Cancer Center |
New York, New York 10021 |